European Journal of Biomedical and Pharmaceutical Sciences

DEVELOPMENT OF RESTRICTIVE LUNG DISEASES IN DIABETIC PATIENTS

Harsh Chapadia, Rassam Khan, Milan Gajera, Tapan Miyani, Milisha Lal, Rumana Tokaria, Pranav Patel and Abhishek Vadher*

ABSTRACT

Introduction: Diabetes is a disease which affects many systems. The effects of Diabetes on lungs in poorly understood. Different studies show different results. Hence, in this study, we tried to find the effects of long standing diabetes on lungs by checking pulmonary function test. Materials and Methods: In this study, we took 40 diabetics and 40 control patients. Diabetics with age between 40 and 60, >10 year of diabetes history and with proper sugar controls were taken. Patients with any renal, liver or metabolic complications were excluded. FEV1, FVC and FEV1/FVC were measured using spirometry. Results: FVC in the diabetes group was 91.45±8.67 and in the control group was 74.86±14.95. P value was 0.05 and hence the finding was not significant. Conclusion: In patients with diabetes, FEV1 and FVC are reduced. FEV1/FVC ratio was not significantly different from the controls. Hence, diabetes can possibly lead to restrictive lung disease in long term.

Keywords: Diabetes is a disease which disease in long term.